Impact · Portfolio Medium horizon Conceptual

One Health

A public-good deployment portfolio for using one shared environmental-biological-operational twin to improve disease early warning, health-system resilience, environmental surveillance, food safety, and precision public health simultaneously.

1. Executive Summary

This memo consolidates the five-paper τ One Health portfolio into a single public-good opportunity architecture.

Under the explicit working stance of this memo, we assume that the τ framework is:

  • sound and semantically well-defined,
  • capable of materially improved bounded-error environmental, biological, and operational prediction,
  • capable of integrating weather, hydrology, ecology, infrastructure, and physiology layers into one coherent causal model,
  • and practically deployable in staged form through conventional data and software interfaces.

Under those assumptions, the One Health cluster becomes one of the strongest and most humane near- to mid-term public-good opportunities in the full τ meta-portfolio.

Why this cluster matters:

  • Human, animal, plant, food, and ecosystem health are deeply coupled.
  • Outbreaks, foodborne disease, AMR, heat stress, smoke exposure, water contamination, and zoonotic spillover all sit at boundaries between domains that are usually modeled separately.
  • Public systems still struggle to connect environmental signals, animal health, facility resilience, surveillance, and response optimization into one actionable picture.
  • A τ-enabled One Health stack would not merely improve one prediction task; it would improve the coherence of the entire prevention-to-response chain.

This memo organizes the cluster into five mutually reinforcing opportunity papers:

  1. τ-Grade One Health Early Warning for Vector-Borne Disease, Zoonotic Spillover, and Climate-Sensitive Outbreaks
  2. τ for Health-System Resilience, Facility Continuity, Cold Chains, and Clinical Operations
  3. τ for AMR, Wastewater/Environmental Surveillance, and Environmental Transmission Intelligence
  4. τ for Food Safety, Livestock/Wildlife Interface, and Community Exposure Intelligence
  5. τ for Precision Public Health, Physiology-Aware Prevention, and Safer Therapeutics / Response Optimization

The portfolio logic is simple:

  • Paper 1 addresses upstream early warning and spillover intelligence.
  • Paper 2 protects the continuity of care during shock.
  • Paper 3 extends surveillance into wastewater and environmental pathways.
  • Paper 4 secures food systems and animal-human interface intelligence.
  • Paper 5 turns the system from population-level response into increasingly precise, safer, more personalized prevention and care.

Together, the five-paper stack creates a staged path from warning to resilience to surveillance to exposure control to precision intervention.

2. Shared τ Framing for the One Health Cluster

2.1 Core Working Assumption

The τ framework is treated here as a candidate bounded-error causal substrate for:

  • environmental dynamics,
  • organismal and ecological state evolution,
  • infrastructure and logistics continuity,
  • and physiology-aware intervention planning.

2.2 Why One Health Is a Particularly Strong Fit

One Health problems are usually hard because they sit across systems:

  • weather and vector habitat,
  • water and pathogen transport,
  • livestock systems and wildlife movement,
  • sanitation and AMR,
  • smoke, heat, and clinical operations,
  • food systems and human exposure,
  • individual risk and population planning.

These are exactly the kinds of cross-domain causal chains that a τ-style unified environmental-biological-operational stack is meant to improve.

2.3 What τ Is Assumed to Contribute

In this memo, τ is assumed to provide:

  • better bounded-error environmental prediction,
  • stronger multiscale causal-chain inference,
  • improved coupling of weather, water, air, ecology, logistics, and physiology,
  • stronger operational forecasting for facilities and public systems,
  • and more reliable scenario simulation for prevention and response.

No claim in this memo depends on immediate proof of the deepest theoretical stance. The portfolio is organized as a deployment hypothesis under the optimistic-feasibility assumptions already adopted across the larger τ public-good program.

3. Portfolio-Level Competitive Landscape

3.1 Incumbent Systems and Programs

The global One Health surveillance and early-warning landscape is populated by a diverse array of established actors, each operating within domain-defined perimeters. Understanding the incumbents is essential for positioning τ as complementary infrastructure rather than a competing system.

WHO Global Outbreak Alert and Response Network (GOARN) is the premier operational mechanism for international outbreak response. Established in 2000, GOARN partners over 250 technical institutions and health networks globally. It is reactive by design — its core mission is rapid response once an event is identified — and does not provide predictive environmental intelligence upstream of case detection.

CDC PREDICT / USAID STOP Spillover programs have explicitly targeted zoonotic spillover risk. PREDICT (2009–2020) discovered over 1,100 novel viruses and built laboratory and surveillance capacity in 31 countries, primarily in Southeast Asia and Africa. STOP Spillover (2020–2025) continued this lineage with an explicit behavior-change and community-based focus. Both programs are evidence-based and field-proven, but their analytical frameworks are largely pathogen-centric rather than cross-domain causal-chain models. They capture wildlife reservoirs and spillover hotspots but do not integrate real-time weather-vector-habitat dynamics or health-system continuity into a single operational picture.

ProMED-mail (Program for Monitoring Emerging Diseases), operated by the International Society for Infectious Diseases since 1994, is the oldest publicly accessible global infectious disease reporting system. It aggregates human-curated outbreak reports and has a strong track record for speed and global reach. Its limitation is its essentially passive, human-curated architecture: it does not produce predictive risk signals or integrate environmental drivers.

Global Health Observatory (WHO) provides the authoritative global data repository for health statistics, disease burden, and indicator tracking. It is a statistical backend, not a real-time predictive system.

HealthMap (Boston Children’s Hospital) applies natural-language processing and machine learning to open-source news feeds, social media, and official reports to generate real-time disease alerts. It is fast and broad-coverage, but its signals are retrospective (detecting events after media mentions emerge) and not grounded in mechanistic environmental causal models.

BioSense (CDC) is the U.S. national syndromic surveillance platform, aggregating emergency department visits and clinical signals for domestic outbreak intelligence. Its geographic scope is primarily national (U.S.) and its architecture is clinical-signal-driven rather than environmental.

ECDC EpiPulse (formerly TESSy and EWRS) provides disease notification and epidemic intelligence within the European Union. It excels in structured official reporting but operates primarily within a national-notification framework and does not provide predictive environmental intelligence.

WOAH WAHIS (World Organisation for Animal Health, World Animal Health Information System) is the global reference system for animal disease events and zoonotic interface monitoring. It tracks official notifications from 182 member countries. Like ProMED, it is fundamentally a reporting and notification system rather than a real-time predictive tool.

National public-health institutes — including the U.S. CDC, UK UKHSA/UKHSA, the European Centre for Disease Prevention and Control (ECDC), Africa CDC, the Indian National Centre for Disease Control, China CDC, and their counterparts in 60+ countries — operate their own national-level surveillance and response infrastructure. These systems are highly capable within their national boundaries but are architecturally siloed from each other and from environmental monitoring agencies.

3.2 The Differentiation Argument for a τ-Grade One Health Twin

The incumbents share a structural limitation: each was designed for one domain or one mission. Animal health surveillance does not speak to vector habitat models. Facility resilience planning does not receive real-time watershed pathogen load forecasts. National outbreak notification systems do not integrate the upstream agricultural and ecological dynamics that govern spillover pressure.

A τ-grade environmental-ecological-physiological-operational causal twin offers a fundamentally different architecture. The central differentiation is unified cross-domain causal chain modeling: the ability to reason continuously from weather anomaly to vector habitat shift to wildlife population movement to livestock-wildlife boundary stress to market-chain exposure to human case onset to health-facility load — within one substrate, with propagating uncertainty bounds, at policy-actionable lead times.

This is not a marginal improvement over HealthMap’s speed or GOARN’s operational coordination. It is a different layer of the intelligence stack: predictive, mechanistic, cross-domain, and coarse-grainable from continental to sub-district resolution. Where incumbent systems answer “what is happening now,” a τ One Health twin can, under the working assumptions of this portfolio, answer “what is likely to happen next, where, and through what causal pathway.”

The competitive position is therefore complementary and upstream: τ is not a replacement for GOARN’s operational coordination or ECDC’s reporting infrastructure. It is the missing predictive causal layer that feeds those systems earlier, better-targeted intelligence — and that connects them to each other through a shared environmental substrate.

3.3 Barriers and How They Are Addressed

Institutional inertia is the primary barrier. WHO, CDC, and ECDC are large bureaucracies with deeply established reporting standards and vendor relationships. Penetration strategy for τ should not be direct competition with core reporting systems. Instead, the recommended entry points are:

  • Shadow-mode pilots alongside existing early-warning tools, building transparent performance benchmarks,
  • Decision-support APIs that feed τ risk signals into existing dashboards without requiring system replacement,
  • Bilateral partnerships with regional bodies (Africa CDC, SEARO, PAHO) who are actively investing in next-generation predictive capacity and face fewer legacy-system constraints,
  • and wastewater / environmental surveillance as the first operational beachhead, where the incumbent landscape is least mature and τ’s environmental modeling advantage is most immediately legible.

4. Quantitative Finance Architecture

4.1 Named Funding Windows

The One Health financing landscape is large, growing, and structurally supportive of the τ deployment thesis. The following windows represent realistic institutional entry points.

World Bank One Health Investment (~$2B committed). The World Bank’s One Health Program, formalized under the 2022 One Health Joint Plan of Action, has committed approximately $2B across IDA and IBRD windows for strengthening the human-animal-environment health interface in low- and middle-income countries. Focus areas include zoonotic disease prevention, AMR, food safety, and environmental health capacity. This is a direct match for Papers 1, 3, and 4 of the portfolio.

World Bank / WHO Pandemic Fund (~$2B+ pledged). Established at the G20 Bali Summit in November 2022, the Pandemic Fund has received over $2B in pledges from 24 contributing countries plus the European Commission. It operates as a financial intermediary fund (FIF) at the World Bank. Grant windows cover prevention, preparedness, and response, with a strong stated interest in early-warning systems and surveillance infrastructure. Paper 1 and Paper 2 are directly aligned with Pillar 1 (prevention) and Pillar 2 (preparedness) of the Pandemic Fund investment framework.

CEPI ($4B target for 100-day vaccine mission). The Coalition for Epidemic Preparedness Innovations has a stated goal of compressing vaccine development from potentially years to 100 days by 2025–2030. Achieving this requires much earlier outbreak detection signals — precisely what Paper 1 aims to provide. CEPI’s investment in outbreak intelligence platforms is a natural partnership channel, particularly for novel zoonotic pathogen emergence scenarios.

Global Fund ($4B/year grants, expanding to climate-health links). The Global Fund to Fight AIDS, Tuberculosis and Malaria disburses approximately $4B annually in grants to national programs, with expanding eligibility criteria that increasingly include climate-health nexus investments (formalized at the 2022 Seventh Replenishment). Papers 1, 2, and 3 could support Global Fund-financed national programs through improved surveillance and facility resilience tooling.

Green Climate Fund (GCF) — health-climate nexus windows. The GCF has financed climate-health adaptation projects in multiple countries, with a growing portfolio addressing climate-sensitive disease, heat-stress health impacts, and WASH-health links. The GCF’s cross-sectoral mandate is particularly receptive to the kind of integrated environmental-health modeling that defines the τ One Health approach.

USAID Global Health (~$10B+ per year). USAID’s Global Health budget is the largest bilateral global health investment, spanning malaria, TB, HIV, maternal and child health, and emerging infectious diseases. The Bureau for Global Health runs programs directly relevant to Papers 1 through 4, including the Infectious Disease Detection and Surveillance (IDDS) project, the Integrated Health Project family, and the Digital Square program for health data systems. Entry via IDDS or Digital Square technical partners is a realistic channel.

Wellcome Trust (~$1B/year grants). Wellcome’s infectious disease, health data, and climate-health programs represent a foundation-sector complement to the multilateral windows above. Wellcome has been an early and consistent investor in wastewater surveillance (through the Wellcome SEDIMENT project and others), AMR surveillance, and predictive epidemiology tooling — making Paper 3 a particularly natural fit.

4.2 Portfolio Cost Scenario

A full five-paper One Health intelligence deployment across a representative regional health corridor (5-year horizon, covering a population of 50–150 million across 3–5 countries) is estimated at $40–100M all-in, inclusive of:

  • data integration infrastructure and partnerships with national public-health institutes,
  • τ software engineering and deployment,
  • sentinel pilot operations (Papers 2 and 1, Phase 1),
  • regional scaling and operational integration (Papers 1–4, Phase 2),
  • training, capacity building, and governance architecture,
  • external validation and audit.

This cost range is consistent with comparable multi-country digital health and surveillance deployments (e.g., USAID IDDS at ~$60M/5 years, Africa CDC APSED at ~$30–50M/cycle).

4.3 Benefit-Cost Anchors

The World Bank and WHO offer converging quantitative anchors for the prevention economics of One Health investment:

  • COVID-19 cost the global economy an estimated $28T (IMF/World Bank, 2020–2022 combined GDP impact), against a prevention investment deficit of approximately $1–5B/year in pre-pandemic early-warning and response preparedness.
  • World Bank analysis of pandemic preparedness investments estimates benefit-to-cost ratios in the range of 10:1 to 50:1 for prevention versus reactive response infrastructure, particularly for zoonotic spillover detection and rapid response.
  • CEPI’s 100-day vaccine mission estimates that shaving 100 days off outbreak-to-vaccine timelines could save $3.6T in expected economic value per major epidemic (based on COVID-19 duration modeling).
  • At a conservative 10:1 B:C ratio, a $40M five-year deployment in a regional corridor targets $400M in avoided disease burden and response costs over the period — before counting lives saved, hospitalization reduced, or institutional disruption avoided.

The key economic insight for τ One Health is that the marginal cost of earlier warning is low relative to the marginal benefit of reduced outbreak response cost. The 2014–2016 West Africa Ebola response cost approximately $53B in response and GDP impact across Guinea, Liberia, and Sierra Leone alone. A $5–10M early-warning pilot that shortens outbreak detection by 7–14 days in that corridor would need to avoid only a fraction of one large outbreak to achieve positive return on investment at institutional investment horizons.

5. Five-Paper Architecture

5.1 Paper 1 — τ-Grade One Health Early Warning for Vector-Borne Disease, Zoonotic Spillover, and Climate-Sensitive Outbreaks

Primary scope:

  • vector habitat suitability,
  • outbreak early warning,
  • rainfall-temperature-humidity-linked disease risk,
  • zoonotic interface intelligence,
  • and anticipatory public-health action.

Public-good logic:

  • earlier warnings,
  • fewer avoidable infections,
  • better targeting of scarce surveillance and response resources.

5.2 Paper 2 — τ for Health-System Resilience, Facility Continuity, Cold Chains, and Clinical Operations

Primary scope:

  • hospital and clinic continuity,
  • outage/heat/flood/smoke resilience,
  • oxygen, cooling, and power dependencies,
  • vaccine and medicine cold chains,
  • and continuity of essential clinical operations.

Public-good logic:

  • fewer service interruptions,
  • safer care during compound shocks,
  • more resilient primary care and emergency systems.

5.3 Paper 3 — τ for AMR, Wastewater/Environmental Surveillance, and Environmental Transmission Intelligence

Primary scope:

  • wastewater epidemiology,
  • environmental AMR pathways,
  • sanitation-linked transmission,
  • real-time and basin-scale environmental surveillance,
  • and earlier detection of pathogen and resistance patterns.

Public-good logic:

  • earlier intervention,
  • stronger infection prevention,
  • more targeted surveillance,
  • lower downstream disease burden.

5.4 Paper 4 — τ for Food Safety, Livestock/Wildlife Interface, and Community Exposure Intelligence

Primary scope:

  • foodborne disease prevention,
  • animal-human interface monitoring,
  • livestock/wildlife boundary risk,
  • market-chain contamination,
  • and community exposure intelligence.

Public-good logic:

  • fewer foodborne illnesses,
  • better livestock and wildlife health intelligence,
  • less zoonotic spillover pressure.

5.5 Paper 5 — τ for Precision Public Health, Physiology-Aware Prevention, and Safer Therapeutics / Response Optimization

Primary scope:

  • stratified prevention,
  • physiology-aware care planning,
  • medication safety and dosing support,
  • adaptive intervention design,
  • and safer, more effective operational public health.

Public-good logic:

  • fewer avoidable harms,
  • more effective prevention,
  • more individualized but scalable decision support.

6. Ranked Rollout Lenses

6.1 Lens A — Fastest Near-Term Public Good

  1. Paper 2 — Health-system resilience and continuity
  2. Paper 1 — One Health early warning
  3. Paper 3 — Wastewater/environmental surveillance
  4. Paper 4 — Food safety and exposure intelligence
  5. Paper 5 — Precision public health

Rationale: Paper 2 and Paper 1 affect life-and-service continuity quickly. Paper 3 has high surveillance value and can often piggyback on existing sampling and public-health infrastructure. Paper 4 is highly important but often cross-ministerial and operationally fragmented. Paper 5 is likely highest value over time but more deployment-complex.

6.2 Lens B — Highest Humanitarian Burden Reduction

  1. Paper 1
  2. Paper 2
  3. Paper 4
  4. Paper 3
  5. Paper 5

Rationale: Outbreak prevention, vector control, and spillover warning can reduce large-scale burdens. System continuity protects large populations during shocks. Food safety and livestock/wildlife intelligence affect enormous exposed populations.

6.3 Lens C — Strongest τ Signature

  1. Paper 1
  2. Paper 3
  3. Paper 2
  4. Paper 4
  5. Paper 5

Rationale: The strongest distinctive τ advantage likely appears where environmental, ecological, and biological chains must be modeled together.

  1. Paper 2
  2. Paper 1
  3. Paper 3
  4. Paper 4
  5. Paper 5

This order balances immediacy, public-good scale, feasibility, and τ differentiation.

7. Opportunity Scoring Matrix

Scoring scale: 1 (lower) to 5 (higher)

Paper Public-good upside Near-term feasibility Institutional readiness τ differentiation Data availability Overall priority
Paper 1 — Early warning 5 4 4 5 4 Very High
Paper 2 — Health-system resilience 5 5 4 4 4 Very High
Paper 3 — AMR + wastewater/environment 5 4 4 5 4 Very High
Paper 4 — Food safety + interface intelligence 4 4 3 4 3 High
Paper 5 — Precision public health 5 3 3 5 3 High / Strategic

8. Portfolio-Level Case Studies

8.1 Case Study 1 — East Africa One Health Chain: Rift Valley Fever, MERS, and Brucellosis Corridor

Papers activated: Paper 1 (vector-borne early warning) + Paper 4 (livestock/wildlife interface) + Paper 3 (environmental surveillance)

Geography and burden: The East African Rift Valley corridor — spanning Ethiopia, Kenya, Tanzania, Uganda, Somalia, and Sudan — is one of the world’s most active zoonotic spillover zones. The region carries an estimated annual burden of more than 1 million clinical cases of zoonotic disease from Rift Valley Fever (RVF), Brucellosis, anthrax, and other livestock-associated pathogens. MERS-CoV has been detected in dromedary camel populations from Kenya to Egypt. The 2006–2007 RVF epidemic in East Africa caused approximately 1,000 confirmed human cases, 300 deaths, and $60M in livestock losses across Kenya, Tanzania, and Somalia alone.

The causal chain that τ targets: East Africa RVF follows a tightly coupled environmental pathway: elevated Indian Ocean sea-surface temperatures drive above-average rainfall over semi-arid rangelands → standing water supports explosive Aedes and Culex mosquito breeding → mass emergence coincides with calving season in pastoral livestock systems → livestock amplification precedes human spillover by 2–4 weeks → human outbreak detection through clinical surveillance lags a further 2–3 weeks.

Under current surveillance architecture, the cumulative detection lag is 4–7 weeks. During that window, preventive vaccination of at-risk livestock, targeted vector control, and community early-warning are all feasible — but rarely achieved due to lack of advance signal. Paper 1 in the τ portfolio directly targets this gap: integrating SSTA forecasts, rainfall-vector habitat models, and livestock distribution into a single actionable early warning with 4–8 week lead time.

Paper 4 extends this further: a τ-enabled livestock-wildlife interface model for the Rift Valley corridor would track pastoral livestock movement, Aedes spp. habitat suitability, and abattoir/wet market exposure pathways in a single substrate, enabling district-level targeting of surveillance and intervention resources.

Paper 3 adds basin-scale environmental surveillance: wastewater monitoring in Nairobi, Kampala, Addis Ababa, and Mombasa could detect circulating RVF and Brucella markers 7–14 days before clinical case counts signal an outbreak.

Institutions and entry points: Africa CDC (Addis Ababa) is the primary institutional anchor. Its Integrated Disease Surveillance and Response (IDSR) program covers all 55 AU member states and is actively investing in predictive intelligence capacity. The International Livestock Research Institute (ILRI, Nairobi) maintains the most comprehensive East Africa zoonotic interface datasets globally. Kenya NCDC, Ethiopia Public Health Institute (EPHI), and Uganda National Institute of Public Health (UNIPH) are operational partners. FAO’s Emergency Prevention System (EMPRES) for animal health monitors the RVF corridor continuously.

Impact potential: A targeted deployment of Papers 1+3+4 across the Kenya-Ethiopia-Tanzania-Uganda corridor (population ~200M, livestock population ~250M cattle-equivalent) is estimated to reduce outbreak detection lag by 4–6 weeks, enabling anticipatory response for 30–50% of RVF epidemic events under historical recurrence patterns. A single avoided epidemic of 2006–2007 scale would more than recover a five-year deployment investment.

8.2 Case Study 2 — South/Southeast Asia AMR and Climate Chain: Wastewater Intelligence During Monsoon Flooding

Papers activated: Paper 3 (wastewater/environmental surveillance) + Paper 2 (health-system resilience)

Geography and burden: South and Southeast Asia carry the world’s highest absolute burden of antimicrobial-resistant infections. The WHO GLASS (Global Antimicrobial Resistance and Use Surveillance System) reports that South Asia accounts for over 30% of global AMR-attributable deaths — approximately 690,000 deaths per year in India alone by some estimates (Lancet, 2022). Bangladesh, Pakistan, Thailand, Vietnam, and Indonesia face compounding AMR burdens from dense urban populations, high antibiotic use, and severely stressed sanitation systems.

Monsoon flooding — intensifying under climate change — creates the single most dangerous annual amplifier of AMR transmission. Flooding overwhelms urban wastewater systems, dispersing AMR organisms from hospital effluent, livestock waste, and untreated domestic sewage across residential and market areas simultaneously. The 2017 Bangladesh flood season was associated with a 40% spike in hospital admissions for waterborne and AMR-associated infections across Dhaka and Chittagong divisions.

The causal chain that τ targets: The Paper 3 entry point is monitoring wastewater AMR gene abundance and pathogen load at strategic urban catchment points (river intakes, urban drains, hospital effluent outlets) across a monsoon-season basin. Integrated with τ’s hydrological flooding models, this enables:

  • pre-monsoon baseline AMR profiling,
  • real-time detection of AMR surge as flood inundation begins,
  • 48–72 hour predictive alerts for secondary care hospitals in flood-affected districts,
  • targeted public-health messaging and clinical antimicrobial stewardship guidance.

Paper 2 activates in parallel: hospitals in flood-affected districts receive τ-modeled continuity risk forecasts covering oxygen supply, cold-chain pharmacy stocks, power and generator fuel logistics, and isolation ward capacity — all under the same flooding scenario that is driving AMR transmission in the community. The combination enables integrated anticipatory response rather than sequential crisis management.

Institutions and entry points: WHO South-East Asia Regional Office (SEARO, New Delhi) coordinates AMR and WASH policy across 11 member states. SEARO has a standing AMR Steering Group and is actively building wastewater surveillance capacity under the WHO Water, Sanitation, Hygiene and Health (WASH) program. icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh) operates the world’s most respected clinical and environmental surveillance for waterborne pathogens in a monsoon-zone megacity. The Public Health Foundation of India (PHFI) and the National Institute for Communicable Diseases (NICD, South Africa, for comparative benchmarking) are natural partners.

Impact potential: Deployment of Papers 2+3 in a five-city South Asian corridor (Dhaka, Mumbai, Ho Chi Minh City, Bangkok, Karachi — combined population ~85M) would extend wastewater-based AMR surveillance to cities currently below WHO GLASS reporting thresholds, while providing monsoon-season continuity planning intelligence to approximately 400 major hospitals. An improvement of 48–72 hours in anticipatory response time for AMR transmission events is consistent with published evidence that earlier clinical antimicrobial stewardship intervention reduces AMR mortality by 15–25% per episode.

8.3 Case Study 3 — West Africa Epidemic Preparedness: From Early Warning to Facility Continuity to Precision Targeting

Papers activated: Paper 1 (early warning) + Paper 2 (facility continuity) + Paper 5 (precision public health)

Geography and burden: West Africa remains one of the most acute epidemic risk zones globally, shaped by the 2014–2016 Ebola epidemic (11,000 deaths, $53B economic impact), the 2021–2022 Guinea Ebola resurgence, the ongoing mpox transmission in DRC and neighboring states, and the persistent Lassa fever endemic zone across Nigeria, Sierra Leone, Liberia, and Guinea. Nigeria alone carries an estimated annual Lassa burden of 100,000–300,000 infections and 5,000 deaths. The region’s health system capacity is among the most constrained globally: Nigeria has approximately 4 hospital beds per 10,000 population (vs. WHO minimum recommendation of 25); Sierra Leone and Liberia had fewer than 1 doctor per 10,000 at the height of the 2014 Ebola outbreak.

The three-paper chain: Paper 1 provides the upstream signal: integrating rainfall, humidity, temperature, land-cover change (forest edge fragmentation driving bat habitat overlap with human settlements), and livestock trade corridor dynamics into a unified Lassa fever and Ebola risk surface. The key predictive target is not “is there an outbreak?” but “where is spillover pressure building, and what is the 30–60 day trajectory?” This enables Nigeria CDC and Africa CDC to pre-position rapid response teams before index case confirmation, a capability that did not exist during 2014.

Paper 2 addresses the catastrophic failure mode that transformed the 2014 Ebola outbreak into a humanitarian crisis: health-system collapse. Hospitals became amplification sites rather than containment sites because facility continuity planning — personal protective equipment logistics, isolation capacity, staff rotation under quarantine protocols, cold-chain for blood products and vaccines — failed under surge conditions. A τ-assisted facility continuity twin for West African district and referral hospitals would provide anticipatory capacity planning for PPE depletion, generator fuel, and patient isolation space under outbreak scenarios derived from Paper 1’s risk surface.

Paper 5 adds precision targeting: once the environmental risk surface and facility capacity intelligence are established, the next frontier is stratified prevention — identifying the specific sub-populations and geographic clusters with highest exposure probability and lowest health-system access, and routing prevention resources (vaccination, community health worker outreach, market-intervention messaging) toward maximum impact. Precision public health in West Africa is not individualized genomic medicine; it is the ability to target scarce community health worker time and reactive vaccination stock at the right neighborhoods before outbreak peaks.

Institutions and entry points: Africa CDC (Addis Ababa) is the continental anchor. Nigeria CDC (Abuja) is the most operationally advanced national institute in the sub-region and has been an active partner for GOARN, WHO, and U.S. CDC programs since 2016. Wellcome Trust has been a major funder of Lassa fever research and vaccine development in West Africa (Wellcome-supported Irrua Specialist Teaching Hospital program in Nigeria). USAID’s West Africa Regional Health Office (Accra) is an established funding and partnership channel. The Mano River Union countries (Guinea, Sierra Leone, Liberia) have a standing regional health cooperation framework that provides an institutional chassis for multi-country deployment.

Impact potential: A deployment of Papers 1+2+5 across Nigeria plus the Mano River corridor (combined population ~280M, Lassa fever endemic zone ~170M at risk) targeting a 50% reduction in outbreak-to-response lead time (from current 14–21 day average to 7–10 days) and a 20% improvement in facility continuity during outbreak surge events is consistent with World Bank and WHO estimates of 10:1 to 50:1 benefit-to-cost ratios for early epidemic preparedness investments. Even under conservative assumptions, preventing one Lassa epidemic escalation equivalent to the 2018 Nigeria outbreak (over 500 confirmed cases, ~150 deaths, and widespread health system disruption) would yield a return exceeding a full five-year deployment cost.

9. Lighthouse Pilots

9.1 Pilot 1 — Climate-Sensitive Disease Early Warning Stack

Combine:

  • vector suitability,
  • rainfall and temperature anomalies,
  • water and sanitation stress,
  • land-use interface risk,
  • and public-health operations planning.

Potential partners: WHO regional offices, FAO, national public-health institutes, ministries of health and agriculture, epidemic intelligence programs.

Success metrics: outbreak-detection lag reduction, vector-control resource targeting quality, anticipatory action lead time, surveillance coverage, false-alarm ratio.

9.2 Pilot 2 — Heat/Flood/Smoke Hospital Continuity Twin

Target:

  • hospitals,
  • clinics,
  • laboratories,
  • oxygen systems,
  • cold chains,
  • dialysis and electricity-dependent patient support.

Potential partners: Ministries of health, hospital systems, WHO, Red Cross / Red Crescent, national disaster agencies.

Success metrics: cold-chain failure reduction, service interruption reduction, continuity of essential care during events, restoration-time improvement, patient safety indicators.

9.3 Pilot 3 — Wastewater + AMR Sentinel Basin

Combine:

  • wastewater surveillance,
  • antimicrobial resistance pathways,
  • stormwater overflow risk,
  • sanitation network stress,
  • and hotspot targeting.

Potential partners: Public-health labs, sanitation utilities, WHO, UNEP-linked programs, national AMR taskforces.

Success metrics: outbreak or pathogen detection lead time, AMR hotspot identification quality, surveillance coverage expansion, targeted intervention rate, detection-to-action time.

9.4 Pilot 4 — Foodborne Risk and Livestock/Wildlife Interface Corridor

Target:

  • high-risk livestock zones,
  • wet markets or market corridors,
  • peri-urban food-supply systems,
  • wildlife boundary hotspots.

Potential partners: Ministries of agriculture, WOAH networks, food-safety authorities, FAO, regional epidemiology centers.

9.5 Pilot 5 — Physiology-Aware Prevention and Therapeutics Sandbox

Target:

  • medication-safety decision support,
  • outpatient risk stratification,
  • heat-sensitive and chronic-disease populations,
  • adaptive care pathways.

Potential partners: Health systems, regulators, digital-health groups, pharmacology and model-informed-dosing programs.

10. Phased Deployment Roadmap

10.1 Phase 1 — 0 to 24 Months

Focus: Data integration, shadow-mode analytics, sentinel pilots, retrospective validation, and institutional trust-building.

Priorities: Paper 2 pilot, Paper 1 pilot, early Paper 3 integration.

Deliverables: Risk dashboards, continuity maps, bounded-error nowcasting/forecasting prototypes, operational advisories in shadow mode.

10.2 Phase 2 — 2 to 5 Years

Focus: Decision support embedded in operations, regional scaling, public-system integration, and linked environmental-health workflows.

Priorities: Expand Papers 1 and 2 nationally or regionally; operationalize Paper 3 surveillance; launch Paper 4 pilots in selected food-system corridors.

Deliverables: Integrated early-warning systems, facility continuity protocols, wastewater/environmental dashboards, food and exposure intelligence products.

10.3 Phase 3 — 5 to 10+ Years

Focus: Deeply integrated One Health twins, precision prevention, multi-ministry planning systems, physiology-aware adaptive response.

Priorities: Mature Paper 5; link all five papers into a coherent national or regional One Health operating system.

Deliverables: Unified public-health and environmental planning twins, precision prevention layers, safer therapeutics and response optimization frameworks.

11. SDG Mapping and Regulatory Alignment

11.1 Sustainable Development Goals

The τ One Health portfolio has direct, substantive alignment with six of the seventeen SDGs.

SDG 3 — Good Health and Well-Being. The portfolio’s core mandate aligns with SDG 3.3 (ending epidemics of AIDS, TB, malaria, and neglected tropical diseases; combating hepatitis, water-borne diseases, and other communicable diseases) and SDG 3.d (strengthening international health security and the capacity for early warning, risk reduction, and management of national and global health risks). All five papers contribute to SDG 3.3 and 3.d through earlier detection, improved facility continuity, and stronger environmental surveillance.

SDG 6 — Clean Water and Sanitation. Paper 3 (wastewater and environmental surveillance) directly operationalizes SDG 6 by integrating water quality, sanitation network monitoring, and waterborne pathogen detection into a single basin-scale framework. SDG 6.3 (improving water quality, reducing pollution, and eliminating unsafe disposal) and SDG 6.b (supporting local communities in improving water and sanitation) are both addressable through wastewater epidemiology partnerships.

SDG 2 — Zero Hunger. Paper 4 (food safety and livestock/wildlife interface) directly supports SDG 2.1 (food security and access to safe food) and SDG 2.4 (sustainable food production systems). The τ food-safety intelligence layer reduces foodborne disease burden and improves supply-chain pathogen surveillance — core SDG 2 outcomes.

SDG 13 — Climate Action. Papers 1 and 2 directly address climate-sensitive disease risk and health-system resilience under compound climate events. SDG 13.1 (strengthen resilience and adaptive capacity to climate-related hazards) is central to both paper missions. The climate-health nexus is increasingly recognized by UNFCCC, WHO, and the GCF as requiring integrated environmental-health modeling — precisely the τ value proposition.

SDG 15 — Life on Land. Paper 4 addresses the wildlife-human interface and Paper 1 addresses land-cover change and zoonotic spillover — both directly relevant to SDG 15.8 (prevent the introduction of invasive alien species) and SDG 15.5 (reduce degradation of natural habitats and halt the loss of biodiversity). One Health surveillance at the livestock-wildlife boundary is an implementation mechanism for multiple SDG 15 targets.

SDG 10 — Reduced Inequalities. Equitable access to One Health intelligence — ensuring that lower-income countries and rural, indigenous, and marginalized communities receive the same quality of early warning and prevention as high-income urban populations — is a core governance commitment of this portfolio and directly relevant to SDG 10.2 (promote the social, economic, and political inclusion of all).

11.2 International Health Regulations (IHR 2005) Alignment

The WHO International Health Regulations (2005) establish binding obligations for 196 signatory states to develop core capacities in surveillance, laboratory, zoonotic disease surveillance, food safety, chemical events, and radiation emergencies. The τ One Health portfolio is directly aligned with:

  • IHR Annex 1, Core Capacity 1 (legislation, policy, and financing for IHR implementation),
  • IHR Annex 1, Core Capacity 2 (coordination and national focal point communication),
  • IHR Annex 1, Core Capacity 4 (surveillance — “the capacity to conduct active and passive surveillance for events of public health importance, including systematic investigation of potential public health emergency of international concern”),
  • and IHR Annex 1, Core Capacity 7 (zoonotic disease surveillance and control).

11.3 One Health Joint Plan of Action (OH-JPA) Alignment

The One Health Joint Plan of Action 2022–2026, developed by the Quadripartite (WHO, FAO, UNEP, WOAH), identifies five action tracks: zoonotic diseases, antimicrobial resistance, food safety, the human-animal-environment interface, and health and environment. The τ portfolio maps directly to all five tracks and provides the unified predictive substrate that the OH-JPA implicitly requires but does not yet specify technically.

12. Quantified Scenario Bands (5 / 10 / 20 Years)

These are structured planning scenarios, not forecasts. Numerical estimates are calibrated against WHO, World Bank, and CEPI published baselines.

12.1 Five-Year Scenario Band (2026–2031)

Detection and warning:

  • 30–50% reduction in outbreak-detection lag in pilot regions, from the current global average of 14–21 days (WHO GOARN benchmark, post-COVID analysis) to a target of 5–10 days for climate-sensitive vector-borne and zoonotic events.
  • Basis: Published evidence from early wastewater-based epidemiology deployments (COVID-19 WBE programs in Netherlands, UK, Australia) shows 4–7 day lead time advantage over clinical surveillance; τ-grade environmental modeling targets an additional 3–7 days through upstream habitat and ecological signal integration.

Health-system continuity:

  • 10–20% improvement in health facility continuity during compound climate events (combined heat, flood, smoke, power outage scenarios) in pilot hospital networks.
  • Basis: World Bank health facility resilience assessments in climate-vulnerable regions estimate that 20–40% of facility service interruptions during climate events are attributable to inadequate advance planning and resource pre-positioning — gaps directly addressable by a τ facility continuity twin.

Environmental surveillance:

  • Extension of wastewater-based epidemiology coverage to 10–20 cities in low- and middle-income countries currently below WHO GLASS reporting thresholds, adding AMR and pathogen surveillance for approximately 50–100 million urban residents not currently covered.

Resource targeting:

  • Improved targeting of vector-control, vaccination, and outbreak-response resources, with an estimated 15–25% efficiency gain in resource allocation (fewer unnecessary deployments; earlier deployments to actual high-risk zones).

12.2 Ten-Year Scenario Band (2031–2036)

  • Regional One Health intelligence systems operational in at least two of three target corridors (East Africa, South/Southeast Asia, West Africa), providing continuous environmental-ecological-health signal integration to national public-health institutes.
  • Measurable reduction in mortality and morbidity from climate-sensitive outbreaks in covered populations, estimated at 5–15% reduction in annual burden from the top three climate-sensitive diseases per region (basis: WHO estimates that 30–50% of climate-sensitive disease burden is preventable with earlier warning and anticipatory response, and that One Health infrastructure deployments typically achieve 10–30% penetration of preventable burden within 10 years).
  • Reduced foodborne burden in target regions: a 15–25% reduction in foodborne illness detection time is achievable through food-system and market-chain surveillance integration, consistent with FAO-WHO Codex Alimentarius implementation evidence.
  • Stronger AMR environmental response targeting: 2–3 fold improvement in AMR hotspot identification speed in covered cities, consistent with published evidence from mature wastewater surveillance programs (ECDC, 2023).

12.3 Twenty-Year Scenario Band (2036–2046)

  • Systemic shift from reactive to preventive One Health infrastructure as the operational norm in covered regions.
  • One Health becomes institutionally embedded rather than programmatically siloed: environmental monitoring agencies, animal health authorities, national public-health institutes, and health facility networks operate through shared τ-grade intelligence substrates with standardized data exchange protocols.
  • Large reduction in reactive-only health-system behavior: WHO and World Bank projections for well-executed One Health investment over 15–20 years estimate 20–40% reduction in avoidable outbreak escalation rates (events that become epidemics rather than being contained at cluster level).
  • Safer, more adaptive, more physiology-aware public-health systems as the capstone: the integration of precision prevention (Paper 5) into mature One Health infrastructure enables population-level decision support that is simultaneously more individualized and more efficient — the long-run transformational outcome of the portfolio.

13. Common Scorecard

13.1 Five-Year Indicators

  • Reduction in outbreak-detection lag (target: 14–21 days → 5–10 days in pilot regions)
  • Increase in hospital/clinic continuity during heat/flood/smoke/outage events (target: 10–20% improvement)
  • Reduction in cold-chain failures in pilot facility networks
  • Increase in wastewater/environmental surveillance coverage in LMIC cities
  • Reduction in large food-safety event detection time
  • Improved targeting of vector-control and outbreak-response resources (target: 15–25% efficiency gain)

13.2 Ten-Year Indicators

  • Fewer avoidable service interruptions in health facilities
  • Reduced mortality and morbidity from climate-sensitive outbreaks (target: 5–15% in covered regions)
  • Reduced foodborne burden in target regions (target: 15–25% reduction in detection time)
  • Stronger AMR environmental response targeting (target: 2–3× speed improvement)
  • Lower response costs through earlier and better-targeted interventions

13.3 Twenty-Year Indicators

  • Durable One Health institutional integration across at least two of three target regional corridors
  • Large reduction in reactive-only health-system behavior (target: 20–40% reduction in outbreak escalation rates)
  • Stable surveillance-to-response chains across sectors
  • Safer, more adaptive, more physiology-aware public-health systems as standard institutional practice

14. Governance Guardrails (Extended)

Because this cluster touches sensitive health, biological, and environmental data across multiple jurisdictions, governance discipline is critical and non-negotiable. The following eight principles govern all τ One Health deployments.

14.1 Privacy and Rights Protection

No deployment should erode patient privacy, community rights, or data dignity. Health data — including wastewater-derived population health signals, individual clinical records, and environmental exposure data linked to identifiable communities — must be managed under data governance frameworks consistent with national law, WHO data principles, and applicable international human rights obligations. Aggregated signals must be designed to protect individual identifiability at all output layers.

14.2 Non-Discrimination and Fairness

Models must not deepen inequities in surveillance, care, or public-health intervention. Algorithmic outputs must be audited for differential performance across demographic, geographic, and socioeconomic groups. Early-warning systems that systematically under-serve marginalized or low-resource communities while over-serving urban centers or high-income populations would be operationally counterproductive and ethically unacceptable.

14.3 Ecological and Animal Ethics

One Health deployment must not instrumentalize animals or ecosystems purely as inputs to human optimization. The wildlife-health interface surveillance under Paper 4 must operate within ethical frameworks consistent with WOAH animal welfare standards and IUCN wildlife monitoring guidelines. Zoonotic interface monitoring should not become a justification for harmful wildlife management practices. The ecological integrity of monitored systems is a value in itself, not merely a health service input.

14.4 Public Accountability

Early-warning and risk outputs should be auditable, explainable, and proportionate. Outbreak alerts and health-system risk signals must be accompanied by uncertainty quantification and clear communication of model limitations. Systems must be designed so that responsible public-health authorities, independent auditors, and affected communities can interrogate outputs and challenge determinations. Explainability is not a technical nicety — it is an accountability requirement.

14.5 Human Decision Authority

τ should support — not replace — clinical, epidemiological, veterinary, and public-health judgment. No τ output should be designed or deployed as a binding algorithmic decision without human review by qualified practitioners. Decision-support framing, not decision-automation framing, must govern all product and operational design.

Environmental surveillance — including wastewater epidemiology, air quality monitoring, and ecological sampling — generates population-level health intelligence about communities that may not have explicitly consented to surveillance. Deployment protocols must include community engagement and consent processes appropriate to context. Where wastewater surveillance data is used to make public health determinations affecting named communities (e.g., identifying outbreak hotspots), affected communities must have access to the data, the opportunity to contest determinations, and protections against stigmatization or punitive action.

14.7 AMR Stewardship — Surveillance Must Not Incentivize Overprescription

Wastewater and environmental AMR surveillance under Paper 3 must be designed and governed so that its outputs do not inadvertently incentivize overprescription of antimicrobials. Early detection of circulating AMR organisms in a community is an alert for targeted infection prevention, not a signal for broad-spectrum empirical antibiotic prescribing. AMR stewardship — the responsible use of antimicrobial treatments — must be an explicit co-design requirement for any clinical decision-support layer built on Paper 3 outputs. Partnerships with clinical antimicrobial stewardship programs (hospital and community) are mandatory, not optional, in any Paper 3 deployment.

14.8 International Equity in One Health Intelligence Access

There must be a strong affirmative commitment to ensuring that τ-grade One Health intelligence is not structurally captured by high-income countries and high-income health systems. The Global South / Global North gap in surveillance capacity, health data access, and predictive tool deployment is already severe. A deployment architecture that concentrates advanced environmental-health intelligence in well-resourced systems while leaving the highest-burden populations to legacy tools would be both ethically indefensible and strategically counterproductive (since spillover events in under-surveilled regions are the principal source of global epidemic risk). Funding mechanisms, data-sharing frameworks, and deployment priorities must be structured to prioritize equity of access.

Additional principles for fragile and conflict settings: Surveillance deployment in fragile states or conflict settings requires additional protocol layers: protection of surveillance data from military or law-enforcement use, coordination with humanitarian protection principles, and explicit safeguards against disease early-warning information being used to stigmatize or target conflict-affected communities. One Health intelligence in conflict settings must be operationally useful to humanitarian health actors while remaining neutral and protective.

15. Cross-Portfolio Integration Framing

The τ One Health portfolio is the bridge cluster of the full τ meta-portfolio. Its connections to other portfolio domains are not incidental — they are structurally necessary, because One Health problems are defined by their cross-domain character.

Agriculture (Zoonotic Livestock Interface and Food Safety). Papers 1 and 4 are directly coupled to the τ Agriculture portfolio. Livestock health, feed system management, and agricultural land-use change all drive zoonotic spillover dynamics and foodborne disease pathways. The causal chain from agricultural intensification to AMR emergence (through veterinary antibiotic use) connects Paper 4’s livestock/wildlife interface to Paper 3’s AMR surveillance — a linkage that also passes through the Agriculture portfolio’s soil and water modeling infrastructure. Shared τ substrate enables joint deployment and institutional coordination across ministries of health and agriculture.

Water-WASH (Waterborne Disease and Wastewater Surveillance). Paper 3 is the primary intersection with the Water-WASH portfolio. Wastewater epidemiology requires the same basin-scale hydraulic modeling and sanitation network intelligence that underpins water quality management. A τ deployment that serves the Water-WASH portfolio (basin hydrology, flood-overflow risk, sanitation network stress) provides the physical substrate that Paper 3 requires — meaning these two portfolios can and should share deployment infrastructure, data, and institutional partnerships.

Disaster (Health-System Continuity During Compound Events). Paper 2 is the primary intersection with the Disaster portfolio. Health-system resilience is a core component of disaster preparedness. A τ facility continuity twin built for the One Health portfolio directly reuses the compound-event forecasting, infrastructure resilience modeling, and emergency logistics intelligence developed in the Disaster portfolio. Joint deployment pilots (e.g., the Heat/Flood/Smoke Hospital Continuity Twin) are natural entry points for both portfolios simultaneously.

Climate (Climate-Sensitive Disease Range Expansion). Paper 1 draws directly on the climate modeling substrate of the τ Climate portfolio. Dengue, malaria, Lassa fever, Rift Valley Fever, and other vector-borne and zoonotic diseases are among the most climate-sensitive disease categories — their geographic range, seasonal timing, and outbreak intensity are all functions of temperature, rainfall, and humidity dynamics that the Climate portfolio models at scale. A shared climate-ecological substrate enables One Health early warning to be built on top of the same physical infrastructure that serves climate adaptation planning.

Pollution-Circularity (Chemical Exposure and PFAS Health Burden). Paper 3 (environmental surveillance) and Paper 5 (precision public health) intersect with the Pollution-Circularity portfolio at the chemical-health nexus. Persistent organic pollutants, PFAS contamination of water supplies, and heavy-metal environmental exposure all interact with immune function, antibiotic resistance, and chronic disease burden in ways that are currently modeled entirely separately from infectious disease surveillance. A τ environmental health substrate that integrates chemical and biological signals represents a significant long-run convergence opportunity.

Biodiversity (Wildlife-Human Interface). The wildlife-human health interface under Papers 1 and 4 connects directly to the Biodiversity portfolio. Forest fragmentation, wetland loss, and wildlife trade corridor mapping — all central to the Biodiversity portfolio — are primary drivers of zoonotic spillover pressure. The ecological modeling substrate developed for biodiversity applications is the same substrate needed for zoonotic risk mapping. Joint deployment architecture and data-sharing across these two portfolios would reduce duplication and strengthen both.

In the broader meta-portfolio, One Health is the place where human welfare, animal welfare, ecological integrity, and operational resilience most visibly converge. No other cluster requires integration of as many τ substrate layers simultaneously — and no other cluster stands to benefit as much from the full coherence of the τ cross-domain modeling approach.

  1. Finalize the five-paper One Health stack and complete companion papers 2.
  2. Build a short executive One Health brief (2–3 pages) from this memo for institutional circulation with Africa CDC, WHO SEARO, and the Pandemic Fund Secretariat.
  3. Identify and advance 2–3 lighthouse pilots:
    • one outbreak early-warning pilot (East Africa / Horn of Africa corridor recommended),
    • one facility continuity pilot (West Africa hospital network recommended),
    • one wastewater/environmental surveillance pilot (South Asian monsoon-zone city recommended).
  4. Prepare a shared reference architecture for data, governance, and phased deployment, covering IHR 2005 alignment, OH-JPA action tracks, and SDG reporting linkages.
  5. Position One Health as one of the central humane pillars of the larger τ public-good program in all external communications.
  6. Establish AMR stewardship co-design partnerships as a prerequisite for any Paper 3 operational deployment.
  7. Pursue formal introduction with World Bank One Health Program and Pandemic Fund Secretariat (both based in Washington, DC) to explore alignment with upcoming grant windows.

17. Files in This Cluster

  • Paper 1 — τ-Grade One Health Early Warning for Vector-Borne Disease, Zoonotic Spillover, and Climate-Sensitive Outbreaks
  • Paper 2 — τ for Health-System Resilience, Facility Continuity, Cold Chains, and Clinical Operations
  • Paper 3 — τ for AMR, Wastewater/Environmental Surveillance, and Environmental Transmission Intelligence
  • Paper 4 — τ for Food Safety, Livestock/Wildlife Interface, and Community Exposure Intelligence
  • Paper 5 — τ for Precision Public Health, Physiology-Aware Prevention, and Safer Therapeutics / Response Optimization

18. Closing Perspective

Among all τ public-good clusters, One Health may be one of the most ethically resonant.

It asks whether a stronger causal and predictive understanding of the world can reduce not only loss and waste, but also suffering across people, animals, food systems, and ecosystems.

Under the working assumptions of this memo, the answer is yes.

The great practical promise of this cluster is not merely “better outbreak prediction” or “better health analytics.” It is the possibility of moving from fragmented reaction to coherent prevention and resilient care across the living systems on which public health depends.

The competitive landscape analysis in Section 3 makes clear that the incumbents — GOARN, HealthMap, WAHIS, BioSense, and the national surveillance institutes — are well-built for their individual missions. What they cannot do, by design, is reason continuously across the causal chain from weather anomaly to vector habitat to spillover to clinical caseload to facility capacity. That cross-domain coherence is not an incremental improvement over what exists. It is a different layer of the intelligence stack — and it is the layer that has been systematically absent from global One Health architecture.

The finance architecture in Section 4 confirms that the investment case is credible and fundable within existing multilateral windows. The World Bank One Health investment, the Pandemic Fund, CEPI, the Global Fund, and USAID collectively represent more than $20B in annual One Health-adjacent investment — against a global portfolio cost of $40–100M for a five-paper regional deployment that is an order of magnitude smaller than the financing available.

The case studies in Section 8 illustrate that the most compelling early deployments are not speculative. East Africa RVF preparedness, South Asian AMR and monsoon-season wastewater intelligence, and West African epidemic preparedness are real, high-burden, well-institutionally-supported opportunities. The institutions are willing. The data infrastructures are maturing. The financing windows are open.

The governance framework in Section 14 acknowledges, without evasion, that this work touches sensitive territory. Community consent for environmental surveillance, AMR stewardship discipline, equity in Global South access, and conflict-setting protections are not afterthoughts to the technical deployment — they are foundational requirements. Institutions that neglect these dimensions do not merely create ethical risk; they create operational failure modes. Communities that do not trust a surveillance system will not cooperate with it, rendering it incomplete precisely where burden is highest.

The long-run scenario in Section 12 is not a prediction. It is a description of what becomes possible if the portfolio succeeds: a world in which the 14–21 day average outbreak detection lag is halved; in which 400 hospitals across South Asia have anticipatory continuity plans for the monsoon season rather than crisis management protocols during flooding; in which the East Africa RVF corridor receives a 4–8 week early warning before the next epidemic rather than a retrospective notification after it has begun.

That world is not technically beyond reach. It is organizationally, institutionally, and politically within reach — if the intelligence layer required to support it is built with the rigor, equity, and causal coherence that the τ framework, under the working assumptions of this program, is designed to provide.

τ One Health Opportunity Portfolio Memo — Version 2 Date: 2026-03-16 Source: tau_one_health_opportunity_portfolio_memo_draft.md + one-health.json Audience: Ministries of health, agriculture, environment, and education; national public-health institutes; WHO, FAO, WOAH, and UNEP networks; World Bank and Pandemic Fund; humanitarian health actors; digital health groups; public-interest funders.

Companion Papers (4)